News
CAMBRIDGE, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Foghorn ® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious ...
Hosted on MSN1mon
A broken foghorn has been sounding every 30 seconds for weeks, driving people crazyA malfunctioning foghorn has been blaring every 30 seconds off the coast of a Narragansett, Rhode Island, beach for the last few weeks. Narragansett residents spoke to NBC 10 about the relentless ...
Foghorn Therapeutics Inc. announced continued ... with NSCLC as the primary target population. Ongoing first-in-human Phase 1a/b open-label, multicenter trial design for FHD-909 will be presented ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback